UNSPSC 51292916: Dibenzepin

This classification denotes a dibenzazepine and tricyclic antidepressive agent with the molecular formula C18H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 510SJZ1Y6L, chemically known as 5,10-dihydro-10-(2-(dimethylamino)ethyl)-5-methyl-11h-dibenzo(b,e)(1,4)diazepin-11-one but generally known as dibenzepin, which bears US NIH Compound Identifier 9419. European Medicines Agency schedules Dibenzepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07074MIG.

UNSPSC 51292916 Dibenzepin, a Commodity code, does not appear in recent state and local procurement activity. The three most recent opportunities tagged under this code—Seminole County's procurement for Naloxone and safe drug deactivation systems, Texas HHS's Request for Information on direct-to-manufacturer prescription programs, and Minnesota's cooperative purchasing RFP for generic multi-source pharmaceuticals and OTC products—involve naloxone, prescription management systems, and generic pharmaceuticals respectively, none of which align with dibenzepin (a tricyclic antidepressant medication). The mismatch between the code's nominal scope and the actual work being solicited suggests either a tagging error in the opportunities or minimal recent state and local procurement activity specifically for dibenzepin as a single-product commodity.

The recent opportunities do reflect broader state and local pharmaceutical and health-system procurement activity across multiple issuing bodies—county health departments, state HHS commissions, and cooperative purchasing alliances—but none target dibenzepin specifically. No representative opportunities for dibenzepin procurement, response dates, or issuing bodies engaged in active solicitation for this commodity are present in the current state and local market.